{
    "clinical_study": {
        "@rank": "95861", 
        "arm_group": [
            {
                "arm_group_label": "Vibrating capsule", 
                "arm_group_type": "Active Comparator", 
                "description": "patients will receive vibrating capsule for 8 weeks of treatment (1 every 4 days)."
            }, 
            {
                "arm_group_label": "sham vibrating capsule", 
                "arm_group_type": "Sham Comparator", 
                "description": "patients will receive sham vibrating capsule for 8 weeks of treatment (1 every 4 days)."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a study intended to evaluate the efficacy and safety of the vibrating capsule versus\n      sham non-vibrating capsule on spontaneous bowel movement, in aiding reliving Constipated\n      Individuals"
        }, 
        "brief_title": "Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Idiopathic Constipation", 
        "condition_browse": {
            "mesh_term": "Constipation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients aged 18 years and older.\n\n          2. Colonoscopy performed in the past 5 years prior to study participation, unless the\n             patients are <50 years old and without alarming signs and symptoms\n\n          3. Patients with chronic idiopathic constipation according to Rome III  criteria and who\n             have not experienced satisfactory relief of their symptoms from available therapies.\n\n          4. Patients with more than 1 bowel movement/2 weeks and \u22643 bowel movement/week.\n\n          5. Patient signed ICF\n\n          6. For women with childbearing potential, adequate contraception\n\n        Exclusion Criteria:\n\n          1. History of complicated/obstructive diverticular disease\n\n          2. History of intestinal or colonic obstruction.\n\n          3. History of significant GI disorder.\n\n          4. Use of following medication: Medication that may affect the bowel mobility,\n             Prokinetics,  Anti-Depressants, medications for treatment of Parkinson disease,\n             Opiates, Calcium-channel Blockers, Aluminium/Magnesium Hydroxids\n\n          5. Clinical evidence of significant respiratory, CVS, renal, hepatic, biliary,\n             endocrine, psychiatric, neurologic, or presence of abdominal pacemakers.\n\n          6. Presence of pacemaker.\n\n          7. History of, or current eating disorders, such as anorexia, bulimia, or compulsory\n             overeating.\n\n          8. Diagnosis of mega-rectum or colon, a history of intestinal obstruction, congenital\n             anorectal malformation, clinically significant rectocele, or any evidence of\n             intestinal structural abnormality, including GI resection that affects bowel transit,\n             or any evidence of intestinal carcinoma or inflammatory bowel disease of alarm\n             symptoms such as weight loss, rectal bleeding, or anaemia.\n\n          9. Participation in another clinical study in the last 4 months prior to screening.\n\n         10. Any other condition which in the opinion of the investigator may adversely affect the\n             safety of the patient or would limit the patient's ability to complete the clinical\n             study.\n\n         11. Women who are pregnant or lactating. -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02030756", 
            "org_study_id": "Vibrant-14-MS-CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vibrating capsule", 
                "description": "patients will receive vibrating capsule for 8 weeks of treatment (1 every 4 days).", 
                "intervention_name": "vibrating capsule", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "sham vibrating capsule", 
                "description": "patients will receive sham vibrating capsule for 8 weeks of treatment (1 every 4 days).", 
                "intervention_name": "sham vibrating capsule", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "constipation", 
        "lastchanged_date": "April 23, 2014", 
        "location": [
            {
                "contact": {
                    "email": "TANimrodKi@clalit.org.il", 
                    "last_name": "Nimrod Kimchi, MD", 
                    "phone": "972-3-5556559"
                }, 
                "facility": {
                    "address": {
                        "city": "Bat Yam", 
                        "country": "Israel"
                    }, 
                    "name": "Bat-Yamon"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "yishair@tlvmc.gov.il", 
                    "last_name": "Ron Yishai, M.D.", 
                    "phone": "972-3-6974463"
                }, 
                "facility": {
                    "address": {
                        "city": "Tel Aviv", 
                        "country": "Israel"
                    }, 
                    "name": "Souraski Medical Center"
                }, 
                "investigator": {
                    "last_name": "Ron Yishai, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "EranMa@clalit.org.il", 
                    "last_name": "Eran Maoz, MD", 
                    "phone": "972-3-7625245"
                }, 
                "facility": {
                    "address": {
                        "city": "Tel Aviv", 
                        "country": "Israel"
                    }, 
                    "name": "100 Tower"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "change in the frequency of bowel movements - weekly Spontaneous Bowel Movement (SBM) rate -  from baseline to during treatment period", 
            "measure": "Frequency of bowel movements", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02030756"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Vibrant Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vibrant Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}